UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 400

Sortiert nach

Stromal circuits involving tumor-associated macrophages and cancer-associated fibroblasts

Frontiers in immunology, 2023-06, Vol.14, p.1194642-1194642

2023

Link zum Volltext

Verfügbarkeit prüfen

Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients

Proceedings of the National Academy of Sciences - PNAS, 2015-05, Vol.112 (19), p.6140-6145

2015

Link zum Volltext

Verfügbarkeit prüfen

Current Clinical Evidence and Potential Solutions to Increase Benefit of CAR T-Cell Therapy for Patients with Solid Tumors

Oncoimmunology, 2020-01, Vol.9 (1), p.1777064-1777064

2020

Link zum Volltext

Verfügbarkeit prüfen

Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer

Cancer research (Chicago, Ill.), 2022-09, Vol.82 (18), p.3291-3306

2022

Link zum Volltext

Verfügbarkeit prüfen

Site and Timing of First Relapse in Stage III Melanoma Patients: Implications for Follow-Up Guidelines

Journal of clinical oncology, 2010-06, Vol.28 (18), p.3042-3047

2010

Link zum Volltext

Verfügbarkeit prüfen

EJS-2 COVID-19 vaccination in cancer patients

Annals of oncology, 2022-07, Vol.33, p.S409-S409

Romano, Emanuela

2022

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy in breast cancer: an overview of current strategies and perspectives

NPJ breast cancer, 2023-02, Vol.9 (1), p.7-7, Article 7

2023

Link zum Volltext

Verfügbarkeit prüfen

Pulmonary sarcoid-like granulomatosis induced by ipilimumab

Journal of clinical oncology, 2012-06, Vol.30 (17), p.e156-e159

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical activity of ipilimumab for metastatic uveal melanoma

Cancer, 2013-10, Vol.119 (20), p.3687-3695

2013

Link zum Volltext

Verfügbarkeit prüfen

Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients

Journal for immunotherapy of cancer, 2021-06, Vol.9 (6), p.e002932

2021

Link zum Volltext

Verfügbarkeit prüfen

Treatment implications of the emerging molecular classification system for melanoma

The lancet oncology, 2011-09, Vol.12 (9), p.913-922

2011

Link zum Volltext

Verfügbarkeit prüfen

Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer

Nature communications, 2024-04, Vol.15 (1), p.2806-2806

2024

Link zum Volltext

Verfügbarkeit prüfen

Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial

Nature communications, 2023-06, Vol.14 (1), p.3698-3698, Article 3698

2023

Link zum Volltext

Verfügbarkeit prüfen

Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial

BMC cancer, 2021-08, Vol.21 (1), p.1-9, Article 899

2021

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial

Nature communications, 2023-11, Vol.14 (1), p.7018-7018, Article 7018

2023

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial

Nature communications, 2023-12, Vol.14 (1), p.8223-8223, Article 8223

2023

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of Drug Resistance in Cancer Therapy

1st ed. 2018., 2019

Link zum Volltext

Verfügbarkeit prüfen

Predictors of recovering ambulation after hip fracture inpatient rehabilitation

BMC geriatrics, 2018-08, Vol.18 (1), p.201-201, Article 201

2018

Link zum Volltext

Verfügbarkeit prüfen

Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges

Journal of clinical medicine, 2023-01, Vol.12 (3), p.953

2023

Link zum Volltext

Verfügbarkeit prüfen

Immune induction strategies to enhance responses to PD-1 blockade: lessons from the TONIC trial

Journal for immunotherapy of cancer, 2019-11, Vol.7 (1), p.318-4, Article 318

2019

Link zum Volltext

Verfügbarkeit prüfen

Lymphatic vessel density is associated with CD8+ T cell infiltration and immunosuppressive factors in human melanoma

Oncoimmunology, 2018-01, Vol.7 (8), p.e1462878-e1462878

2018

Link zum Volltext

Verfügbarkeit prüfen

Persistence of EBV antigen-specific CD8 T cell clonotypes during homeostatic immune reconstitution in cancer patients

PloS one, 2013-10, Vol.8 (10), p.e78686-e78686

2013

Link zum Volltext

Verfügbarkeit prüfen

59 Integrating deep proteomics profiling with survival analysis to identify novel biomarkers of response to PD-1 blockade in NSCLC patients

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A37-A38

2020

Link zum Volltext

Verfügbarkeit prüfen

The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors

Journal for immunotherapy of cancer, 2015-04, Vol.3 (1), p.15-15, Article 15

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 400

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(373)
Mit Volltextzugriff
(371)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(280)
Life Sciences & Biomedicine
(262)
Humans
(185)
Male
(105)
Female
(97)
Adult
(77)
Oncology
(74)
Middle Aged
(58)
Aged
(53)
Biological And Medical Sciences
(50)
Immunotherapy
(34)
Medical Sciences
(34)
Endocrinology & Metabolism
(33)
Immunology
(27)
Cancer
(26)
Patients
(25)
Italy
(24)
Pharmacology & Pharmacy
(24)
Fundamental And Applied Biological Sciences. Psychology
(22)
Adolescent
(20)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Stromal circuits involving tumor-associated macrophages and cancer-associated fibroblasts

Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients

Current Clinical Evidence and Potential Solutions to Increase Benefit of CAR T-Cell Therapy for Patients with Solid Tumors

Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer

Site and Timing of First Relapse in Stage III Melanoma Patients: Implications for Follow-Up Guidelines

EJS-2 COVID-19 vaccination in cancer patients

Immunotherapy in breast cancer: an overview of current strategies and perspectives

Pulmonary sarcoid-like granulomatosis induced by ipilimumab

Clinical activity of ipilimumab for metastatic uveal melanoma

Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients

Treatment implications of the emerging molecular classification system for melanoma

Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer

Nivolumab plus chemoradiotherapy in locally-advanced cervical cancer: the NICOL phase 1 trial

Neo-CheckRay: radiation therapy and adenosine pathway blockade to increase benefit of immuno-chemotherapy in early stage luminal B breast cancer, a randomized phase II trial

Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial

Author Correction: Paclitaxel plus carboplatin and durvalumab with or without oleclumab for women with previously untreated locally advanced or metastatic triple-negative breast cancer: the randomized SYNERGY phase I/II trial

Mechanisms of Drug Resistance in Cancer Therapy

Predictors of recovering ambulation after hip fracture inpatient rehabilitation

Predictive Biomarkers for Response to Immunotherapy in Triple Negative Breast Cancer: Promises and Challenges

Immune induction strategies to enhance responses to PD-1 blockade: lessons from the TONIC trial

Lymphatic vessel density is associated with CD8+ T cell infiltration and immunosuppressive factors in human melanoma

Persistence of EBV antigen-specific CD8 T cell clonotypes during homeostatic immune reconstitution in cancer patients

First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial

59 Integrating deep proteomics profiling with survival analysis to identify novel biomarkers of response to PD-1 blockade in NSCLC patients

The therapeutic promise of disrupting the PD-1/PD-L1 immune checkpoint in cancer: unleashing the CD8 T cell mediated anti-tumor activity results in significant, unprecedented clinical efficacy in various solid tumors

Suchergebnisse filtern